Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 3458 to 3507 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
autophagy protein 12-like (apg12-like). [source:swissprot;acc:o94817]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.028\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01304\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1730\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chaperone-activity of bc1 complex-like, mitochondrial precursor (chaperone-abc1-like). [source:swissprot;acc:q8ni60]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
215.336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.567\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01303\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
p66 alpha. [source:refseq;acc:nm\_017660]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
167.687\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.455\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.768\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1731\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 2; putative ubiquinone biosynthesis protein aarf. [source:refseq;acc:nm\_052853]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.567\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01303\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription repressor p66 beta component of the mecp1 complex. [source:refseq;acc:nm\_020699]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
167.687\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.455\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.768\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1732\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 4. [source:refseq;acc:nm\_024876]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.567\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01303\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine aminotransferase (ec 2.6.1.5) (l-tyrosine:2-oxoglutarate aminotransferase) (tat). [source:swissprot;acc:p17735]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
167.687\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.455\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.768\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1733\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
240.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.085\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.765\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
aarf domain containing kinase 1. [source:refseq;acc:nm\_020421]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.567\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01303\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1734\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase (ec 3.1.3.25) (impase) (imp) (inositol monophosphatase) (lithium-sensitive myo-inositol monophosphatase a1). [source:swissprot;acc:p29218]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.366\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.118\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.752\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 2; component of the h/aca snornp. [source:refseq;acc:nm\_017838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.081\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01296\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1735\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.018\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.751\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
leucyl-trna synthetase. [source:refseq;acc:nm\_020117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.189\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01296\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1736\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 3 (ec 2.7.1.-). [source:swissprot;acc:q00526]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.753\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.751\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor iif, alpha subunit (tfiif-alpha) (transcription initiation factor rap74). [source:swissprot;acc:p35269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.081\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01296\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1737\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, muscle type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme a) (pfk-a) (phosphofructokinase-m). [source:swissprot;acc:p08237]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.069\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.749\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable leucyl-trna synthetase, mitochondrial precursor (ec 6.1.1.4) (leucine--trna ligase) (leurs). [source:swissprot;acc:q15031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.189\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01296\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1738\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b1. [source:swissprot;acc:p14635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.098\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.844\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.746\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
lipoate-protein ligase, mitochondrial precursor (ec 6.-.-.-) (lipoate biosynthesis protein) (lipoyl ligase) (lipoyltransferase). [source:swissprot;acc:q9y234]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.595\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01289\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1739\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 2 (ec 2.7.1.-) (p33 protein kinase). [source:swissprot;acc:p24941]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.746\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin gamma-1 chain (gamma-1 tubulin) (gamma-tubulin complex component 1) (gcp-1). [source:swissprot;acc:p23258]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
206.595\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.258\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01289\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1740\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
defender against cell death 1 (dad-1). [source:swissprot;acc:p46966]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.358\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.103\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.745\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1741\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division control protein 2 homolog (ec 2.7.1.-) (p34 protein kinase) (cyclin-dependent kinase 1) (cdk1). [source:swissprot;acc:p06493]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
168.145\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.888\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.743\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex 11. [source:refseq;acc:nm\_018679]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.595\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01289\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1742\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.729\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin gamma-2 chain (gamma-2 tubulin). [source:swissprot;acc:q9nrh3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.595\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01289\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1743\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.729\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna cleavage factor i, 59 kda subunit. [source:refseq;acc:nm\_024811]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.176\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.402\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01288\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1744\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.721\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sphingosine-1-phosphate lyase 1; sphingosine-1-phosphate lyase. [source:refseq;acc:nm\_003901]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.423\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
222.215\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01272\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1745\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
4-aminobutyrate aminotransferase, mitochondrial precursor (ec 2.6.1.19) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba aminotransferase) (gaba-at) (gaba-t). [source:swissprot;acc:p80404]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
brca1-associated ring domain protein 1 (bard-1). [source:swissprot;acc:q99728]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.991\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.72\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1746\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-methylthioadenosine phosphorylase (ec 2.4.2.28) (mta phosphorylase) (mtapase). [source:swissprot;acc:q13126]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
223.016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.734\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.718\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine aminotransferase, mitochondrial precursor (ec 2.6.1.13) (ornithine--oxo-acid aminotransferase). [source:swissprot;acc:p04181]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.423\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01272\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1747\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative ribosomal rna methyltransferase 1 (ec 2.1.1.-) (rrna (uridine-2'-o-)-methyltransferase) (jm23 protein). [source:swissprot;acc:q9uet6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.734\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.718\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tfiih basal transcription factor complex helicase subunit (ec 3.6.1.-) (dna-repair protein complementing xp-d cells) (xeroderma pigmentosum group d complementing protein) (cxpd) (dna excision repair protein ercc-2). [source:swissprot;acc:p18074]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.452\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.845\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0127\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1748\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bloom's syndrome protein (ec 3.6.1.-) (recq protein-like 3) (dna helicase, recq-like, type 2). [source:swissprot;acc:p54132]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
215.673\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.971\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01269\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ruvb-like 1 (ec 3.6.1.-) (49-kda tata box-binding protein-interacting protein) (49 kda tbp-interacting protein) (tip49a) (pontin 52) (nuclear matrix protein 238) (nmp 238) (54 kda erythrocyte cytosolic protein) (ecp-54) (tip60-associated protein 54-alpha) (tap54-alpha). [source:swissprot;acc:q9y265]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.086\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.716\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1749\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna mismatch repair protein mlh3 (mutl protein homolog 3). [source:swissprot;acc:q9uhc1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.058\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.485\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01264\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 3 (sh3 domain protein 2c) (een-b2). [source:swissprot;acc:q99963]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.823\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.111\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.712\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1750\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to lim domain only 7 (fragment). [source:sptrembl;acc:q8n6m2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01264\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 2 (spectrin, non-erythroid beta chain 2) (beta-iii spectrin). [source:swissprot;acc:o15020]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.032\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.739\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.707\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1751\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 2 subunit (mu-adaptin 2) (adaptor protein complex ap-1 mu-2 subunit) (golgi adaptor ha1/ap1 adaptin mu-2 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 2) (ap-mu chain family member mu1b). [source:swissprot;acc:q9y6q5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01259\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 1 (spectrin, non-erythroid beta chain 1) (beta-ii spectrin) (fodrin beta chain). [source:swissprot;acc:q01082]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.032\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.739\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.707\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1752\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brca1-associated ring domain protein 1 (bard-1). [source:swissprot;acc:q99728]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.991\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01258\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoacetylglucosamine mutase (ec 5.4.2.3) (pagm) (acetylglucosamine phosphomutase) (n-acetylglucosamine-phosphate mutase) (phosphoglucomutase 3). [source:swissprot;acc:o95394]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.032\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.739\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.707\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1753\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
armet protein precursor (arginine-rich protein). [source:swissprot;acc:p55145]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
206.549\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.844\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.705\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01256\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.549\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.844\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.705\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/